Pharmaceutical Processing World

Since its establishment in 1984, Pharmaceutical Processing has been a key resource for professionals in the pharmaceutical, biopharmaceutical, and biotech sectors, offering updates, insights, and information on the latest technologies and services. From the stages of formulation to packaging and advanced manufacturing, Pharmaceutical Processing World delivers thorough coverage of the newest innovations and best practices in the industry. The publication also provides in-depth analysis on various aspects of the pharmaceutical sector, including new product launches, drug pricing trends, treatment developments, and regulatory updates. Each year, we feature the Big Pharma 50, which highlights the largest pharmaceutical companies and offers valuable information about their research and development investments, top-selling medications, and future drug candidates. Pharmaceutical Processing World’s editorial content addresses important issues in pharmaceutical manufacturing, covering topics such as outsourcing, contract development, smart manufacturing, and the advancements associated with Industry 4.0. We also delve into areas like biologics, biopharmaceutical products, and innovation within the pharmaceutical field. Our audience consists of chemical engineers, technicians, facility managers, and regulatory experts.

Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#3939811

United States

#1576295

Health/Biotechnology and Pharmaceuticals

#1367

Traffic sources

Monthly visitors

Articles

Great Point Partners acquires majority stake in Eutecma

1 week ago | pharmaceuticalprocessingworld.com | Danielle Kirsh

Great Point Partners has acquired a majority stake in Eutecma, a Germany-based developer of reusable and modular temperature-controlled packaging for pharmaceutical cold chain logistics. The investment will support Eutecma’s global expansion strategy, particularly in the U.S. market, and bolster its efforts to reduce emissions and waste in drug shipping and storage. Eutecma supplies passive cooling systems for pharmaceutical, medical and diagnostic applications.
Building a resilient pharma supply chain

3 weeks ago | pharmaceuticalprocessingworld.com | Brian Buntz

The pharmaceutical supply chain ensures medications reach patients safely and on time. About 75% of pharma executives say supply chain disruptions threaten patient health. The industry faces particular concern now: according to the Global Supply Chain Pressure Index (GSCPI), global supply chains witnessed major issues during the COVID-19 pandemic and ongoing geopolitical tensions. Here are steps pharma companies are taking to keep medicines moving.
Moving toward the autonomous lab and what’s possible now

3 weeks ago | pharmaceuticalprocessingworld.com | Brian Buntz

It comes as no surprise that automation and contextualized data are popular topics of conversation in life sciences today. After all, automation drives repeatability, repeatability drives speed and safety, and increased speed and safety means getting critical treatments into the hands of patients as fast as possible.
Pharma ingredient manufacturer Antheia raises $56M Series C

3 weeks ago | pharmaceuticalprocessingworld.com | Sean Whooley

Pharmaceutical ingredient manufacturer Antheia announced today that it raised $56 million in Series C financing. The Menlo Park, California-based company aims to deliver ingredients to transform essential medicine supply chains. It plans to use the financing to expand the commercialization of its first product, Thebaine. The company also plans to launch additional products from its pipeline of more than 70 biosynthetic pharmaceutical ingredients.
Driving success in fast-paced high-tech pharma construction projects

1 month ago | pharmaceuticalprocessingworld.com | Brian Buntz

Getting a manufacturing plant from investment to start-up as quickly as possible is a priority in almost every industry. Yet speed-to-market is even more important when it comes to a biotech or pharmaceutical facility. When going online means getting a lifesaving or health-improving solution into the hands of the people who need them, a heightened sense of urgency and care should guide every step of the project.
Prolific Machines enters FDA program to enhance therapeutics manufacturing platform

1 month ago | pharmaceuticalprocessingworld.com | Danielle Kirsh

Prolific Machines, a biotechnology firm developing optogenetics-based solutions for protein manufacturing, has been accepted into the FDA’s Emerging Technology Program, the company announced this week. The FDA’s Center for Drug Evaluation and Research (CDER) program supports the adoption of novel manufacturing technologies with the potential to improve drug quality and availability.
Roche, Genentech to build $700M plant in North Carolina

1 month ago | pharmaceuticalprocessingworld.com | Sean Whooley

Roche and its Genentech unit today announced plans to invest more than $700 million in a new manufacturing facility in the U.S.The company plans to build a new 700,000 square-foot, state-of-the-art drug manufacturing plant in Holly Springs, North Carolina. It expects to add more than 400 high-wage manufacturing jobs once operational, plus more than 1,500 construction jobs during site development. Holly Springs is located just outside Raleigh in the “Research Triangle” region of North Carolina.
ICU Medical, Otsuka launch joint IV supply chain venture

1 month ago | pharmaceuticalprocessingworld.com | Sean Whooley

ICU Medical and Otsuka Pharmaceutical Factory (OPF) announced the formation of a new joint venture to strengthen supply chain resiliency. In this joint venture, the companies say they formed Otsuka ICU Medical LLC. It aims to strengthen IV solutions supply chains and drive innovation in the North American market. The joint venture follows last year’s agreement that saw ICU Medical aid Otsuka in entering the U.S. IV market.
Amgen to spend $900M to expand U.S. biopharma manufacturing

2 months ago | pharmaceuticalprocessingworld.com | Sean Whooley

Amgen announced that it plans to invest $900 million to expand its pharmaceutical manufacturing facility in Ohio. The expansion brings the total number of jobs created to 750. Amgen’s total investment in Central Ohio now eclipses $1.4 billion. “Amgen has been a leading U.S.-based manufacturer of biologic medicines since 1988.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement

2 months ago | pharmaceuticalprocessingworld.com | Chris Newmarker

Fujifilm Diosynth Biotechnologies, a major contract development and manufacturing organization (CDMO), has entered into a 10-year manufacturing supply agreement with Regeneron Pharmaceuticals, valued at over $3 billion. The deal has the Fujifilm subsidiary providing U.S.-based manufacturing for Regeneron, with planned expansions at Fujifilm’s large-scale biopharmaceutical manufacturing facility in Holly Springs, North Carolina.